ReviewJournal of medicine and life2026
Ethical and management dilemmas in the care of the newborn at the limit of viability: a narrative review.
Review in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Decision-Making at the Limit of Viability in Newborns: Insights from a Survey of Medical Professionals.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are variations among healthcare providers regarding the gestational age considered the threshold of viability. Currently, the World Health Organization sets the lower limit of viability at 22 weeks of gestation, or a birth weight of 500 g, or a birth length of 25 cm. Neonates are not autonomous. The present study aimed to evaluate the factors involved in healthcare professionals' management decisions in cases of neonates born at the margins of viability. A narrative review was conducted, including articles published between 2005 and 2025. We included 55 manuscripts and used the SANRA quality scale for assessment. The various approaches currently used worldwide raise concerns about their potential impact on the quality of care provided to these infants. We explored survey-based evidence regarding perceptions of the limit of viability and therapeutic decisions that raise ethical issues. The lack of coherent national guidelines and legislation represents an important burden for our healthcare system. Clinicians are faced with a dilemma regarding the correct management of infants at the limit of viability: whether to prolong treatment despite possible neurological impairment or to indicate discontinuation of treatment. Prenatal counseling for parents before delivery, along with a multidisciplinary approach, is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.